找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Hematologic Challenges in the Critically Ill; Aryeh Shander,Howard L. Corwin Book 2018 Springer International Publishing AG, part of Sprin

[復(fù)制鏈接]
樓主: 母牛膽小鬼
41#
發(fā)表于 2025-3-28 17:50:38 | 只看該作者
42#
發(fā)表于 2025-3-28 21:33:24 | 只看該作者
43#
發(fā)表于 2025-3-29 02:02:46 | 只看該作者
Hematologic Challenges in ICU Patients with Malignancy,den. Oncogenes activate blood coagulation as an integral feature of neoplastic transformation whereby cancer cells support clot formation and clotting proteins support cancer growth and dissemination. A complex coagulopathy develops characterized by activation of clotting mechanisms to different ext
44#
發(fā)表于 2025-3-29 03:06:22 | 只看該作者
45#
發(fā)表于 2025-3-29 08:01:06 | 只看該作者
46#
發(fā)表于 2025-3-29 13:37:17 | 只看該作者
Current Risks of Transfusion,al risks. Over time, the risks associated with transfusion have become increasingly well understood. However, most clinicians think only of transfusion-transmitted infections such as hepatitis B and C and human immunodeficiency virus in regard to transfusion risk. There are many other transfusion ri
47#
發(fā)表于 2025-3-29 17:19:09 | 只看該作者
Clinical Outcomes and Red Blood Cell Storage, blood cell transfusions (Shehata et al. Transfusion 54:2631-9, 2014; Vincent, JAMA 288:1499-507, 2002; Corwin, Crit Care Med 32:39-52, 2004). Our understanding of the biochemical, structural, and functional changes that occurs to red blood cells with storage – also known as the storage lesion – has
48#
發(fā)表于 2025-3-29 19:43:11 | 只看該作者
49#
發(fā)表于 2025-3-30 01:12:39 | 只看該作者
Therapeutic Apheresis for Hematologic Emergencies,s, most often discarding one (red cells, plasma, white cells, or platelets); and returned to the patient with or without extracorporeal modification or a replacement fluid. Multiple TA modalities can be used in the intensive care setting including therapeutic plasma exchange, red blood cell exchange
50#
發(fā)表于 2025-3-30 06:57:30 | 只看該作者
Intravenous Oxygen Therapeutics: A Revolution in Medicine Yet to Be Realized?,has pursued an oxygen therapeutic since the early 1930s with actually some spotty points of success. There are places in the world today that such agents are available, but they have not realized their potential. Two distinctly different pharmaceutical approaches are under accelerated development: h
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 02:10
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
桂阳县| 新津县| 新津县| 宁明县| 临夏市| 夏邑县| 美姑县| 乌恰县| 大田县| 四会市| 清涧县| 奈曼旗| 霍山县| 诏安县| 四川省| 休宁县| 运城市| 裕民县| 上林县| 淳安县| 景宁| 肇庆市| 墨玉县| 台山市| 宜兴市| 湾仔区| 县级市| 乐清市| 通江县| 肃宁县| 涟源市| 抚宁县| 萍乡市| 澄江县| 常州市| 望都县| 灵宝市| 望谟县| 海晏县| 孙吴县| 庐江县|